A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

Trial Profile

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2018

At a glance

  • Drugs Letrozole (Primary) ; Palbociclib (Primary)
  • Indications Early breast cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms PALLET
  • Most Recent Events

    • 15 Mar 2018 Status changed from recruiting to active, no longer recruiting.
    • 15 Mar 2018 Planned End Date changed from 1 May 2018 to 30 Sep 2019.
    • 22 Feb 2018 Planned End Date changed from 31 Oct 2017 to 1 May 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top